Often, newspapers, magazines and other print publications choose to feature the OmniPod and the people who use it. When possible, we archive these articles for your perusal. Simply click the links below to read more.
An Amazing Race Winner Connects With the Diabetes Community
Sept 2012
This Diabetes Health interview with OmniPod wearer Dr. Natalie Strand discusses the physical, mental and emotional challenges of participating in The Amazing Race and how she and her partner overcame those challenges to win the 17th season. They were the first female team to win and Natalie was the first person with type 1 diabetes to win.
Diabetes: Insulet fortifies its market with record OmniPod units in Q1
May 2012
This Mass Device article reports how Insulet is looking ahead to new records in quarterly sales as it fortifies its position in the insulin management market with boosted manufacturing, extended distribution and a slimmer next-gen. design.
Even with Diabetes your dreams can come true
March 2012
The Arizona Family Examiner interviews dolphin trainer Robyn Cox, focusing on how she held fast to her dream of working with dolphins even after her diagnosis of type 1 diabetes. Robyn talks about how the OmniPod System makes her job in the water much easier.
New technology helps teen musician deal with diabetes
March 2012
WWL-TV - CBS Affiliate New Orleans – Teen Rici Jo Rachal is profiled on her hopes of making it big in the pop music industry with diabetes. The article talks about how the state-of-the-art technology of the OmniPod System is helping her get there.
Diabetes: Insulet inks deal with J&J's LifesScan for next-gen OmniPod
February 2012
This Mass Device article reports how Insulet and Johnson & Johnson will partner to incorporate LifeScan's OneTouch blood glucose monitoring technology into a next-generation OmniPod PDM (Personal Diabetes Manager).
BMX riders don't let diabetes slow them down
November 2011
The Arizona Family Examiner interviews dolphin trainer Robyn Cox, focusing on how she held fast to her dream of working with dolphins even after her diagnosis of type 1 diabetes. Robyn talks about how the OmniPod System makes her job in the water much easier.
San Jose Junior Sharks hockey player doesn't let diabetes stop her
July 2011
This San Jose Mercury News article profiles 12-year-old hockey player Holly Hopwood. She talks about using the OmniPod System to manage her diabetes and how she doesn't let diabetes stop her from playing hockey and doing what she loves.
Diabetic snowboarder chases big mountain lines
June 2011
ESPN profiles professional snowboarder Sean Busby about his diabetes and his snowboarding adventures around the world. Busby talks about managing his diabetes during expeditions and how he uses the OmniPod System to set him up for success.
OutThereColoardo.com: Snowboarder reaches out to those with diabetes
April 2011
This Colorado Springs Gazette story talks about professional snowboarder, and OmniPod wearer, Sean Busby bringing his ski and snowboard camp for people with diabetes to Copper Mountain.
New type of insulin pump – omnipod
March 2011
WPVI – ABC – Scott Benner, father of six-year-old Arden Benner, talks about how Arden uses the OmniPod System to manage her diabetes and how it differs from conventional insulin pumps.
The Best Insulin Pumps for Diabetic Swimmers
May 2011
This Opposing Views story rates the best insulin pumps for swimmers with diabetes. The article gives an overview of the OmniPod System, the Medtronic pump and the Animas Ping. The OmniPod was rated "by far the clear winner for swimmers."
Siphon Effects of Continuous Subcutaneous Insulin Infusion Pump Delivery Performance
Journal of Diabetes Science and Technology, 2010
Researchers tested three conventional pumps (with tubing) along with the OmniPod to quantify the siphon effects in the tubing with continuous subcutaneous insulin infusion (CSII) during basal and bolus insulin delivery. This study demonstrated that changing the position of a conventional CSII pump in relation to the infusion site results in significant changes in insulin delivery especially during low bolus rates.
Copyright © 2010 Diabetes Technology Society
From
Journal of Diabetes Science and Technology, Vol. 4, 2010; 98-103
Reprinted with permission from Diabetes Technology Society.
Clinical Experience with a Tubing-Free Insulin Pump System
Infusystems USA, 2009
A retrospective, 1 year study of clinical experience with the OmniPod System in patients with both Type 1 and Type 2 diabetes and who had previously been on either MDI or pump therapy with a conventional pump. The study showed that the OmniPod system demonstrated improvements in glycemic control with patients previously on MDI.
Copyright © 2009 Infusystems USA
From
Infusystems USA, Vol. 6, 2009; 25-27
Reprinted with permission from Infusystems USA.
In Silico Evaluation Platform for Artificial Pancreatic b-Cell Development—A Dynamic Simulator for Closed-Loop Control with Hardware-in-the-Loop
Diabetes Technology & Therapeutics, 2009
Researchers at the University of California Santa Barbara, Sansum Diabetes Research Institute and Stanford Medical Center successfully created a computer-simulated system to evaluate an artificial pancreas. The “pancreas” is comprised of the OmniPod System and a continuous glucose monitor, governed by an algorithm. The study, funded by the JDRF, streamlines preclinical validation trials, bringing the artificial pancreas closer to reality.
From Diabetes Technology & Therapeutics, Vol 11, 2009; 187-194.
This article was written for research purposes only. Insulet makes no real or implied claims concerning the suitability of this technology for diabetes management using the OmniPod Diabetes Management System.
One Road to Hope: JDRF’s Artificial Pancreas Project at the University of Virginia
In this video, found on the JDRF site, researchers at the University of Virginia Health System, patients and diabetes advocates describe the JDRF Artificial Pancreas Project and its potential impact; then one patient documents his experiences with the clinical trial.
This video was made for research purposes only. Insulet makes no real or implied claims concerning the suitability of this technology for diabetes management using the OmniPod Diabetes Management System.
Pumped Up
November 2008
This HealthMatters story on the history of insulin pumps features Ironwoman Triathlete and OmniPod user Kathy Gagnier. Kathy finds that pump therapy makes her diabetes easier to manage. Note: Kathy personalizes the look of all of her pods with permanent markers. Used by permission of HealthMatters For People With Diabetes and Liberty Medical.
Positive Update: Adventure Photographer Lisa Seaman
March 2008
Diabetes Positive! profiles outdoorswoman and adventure photographer Lisa Seaman. An enthusiastic pumper, Lisa recently switched to OmniPod—and she talks about how the System helps her lead her active lifestyle.
Sky Radio interview with Shawna Gvazdauskas
March 2008
Sky Radio—renowned producers of business, technology and health programming for the airlines and internet—spoke with Insulet’s then Senior Vice President of Sales & Marketing Shawna Gvazdauskas about how the OmniPod System works, and how it is making diabetes a smaller part of life for thousands.
Quantifying the Impact of a Short-Interval Interruption of Insulin-Pump Infusion Sets on Glycemic Excursions
Diabetes Care, 2008
A prospective, open-label study measured the impact of short-term infusion set disconnects on glucose levels. It shows that even short-term interruption of insulin delivery can cause blood glucose levels to rise and remain elevated for hours post-interruption.
Copyright © 2008 American Diabetes Association
From Diabetes Care®, Vol. 31, 2008; 238-239
Reprinted with permission from The American Diabetes Association.
The OmniPod Insulin Management System
November 2007
In a cover story, Diabetes Positive! explores the history of the OmniPod and its advantages over conventional pumps—including its lower start-up costs. Interviewee Anthony Vita notes that the System “has given [him] back [his] life.”
Insulet signs deal to ramp up insulin pump supply
October 4, 2007
Reuters reports that a new deal with Flextronics, one of the largest suppliers of blood glucose meters, will boost Insulet’s production capacity; it further speculates that the OmniPod System’s relative convenience may help encourage more people with Type 2 diabetes to use insulin pumps.
diaTribe: Test Driving Insulet’s OmniPod System
May/June 2007
diaTribe columnist Kelly Close describes her experience with OmniPod, including details of how the System works and how she compares it to other pumps she has used. Close’s conclusion: She would sacrifice her cell phone for an OmniPod.
OmniPod Insulin Management System: Patient perceptions, preference and glycemic control
Diabetes Care, 2006
Diabetes researchers Howard Zisser, MD and Lois Jovanovic, MD detail the results of a 30-day study comparing the OmniPod with conventional insulin pump therapy along metrics of glycemic control, convenience, insertion pain and satisfaction. Subjects showed remarked preference for the OmniPod; importantly, they also showed significantly reduced A1C values.
Copyright © 2006 American Diabetes Association
From Diabetes Care®, Vol. 29, 2006; 2175
Reprinted with permission from The American Diabetes Association.
A ‘Gadget Guy’ Embraces Diabetes
July 2006
Diabetes Health interviews The Diabetic Investor editor David Kliff, on life with the OmniPod System, including his lower A1Cs and the freedom of having no tubing.
Insulin Pump Therapy: A meta-analysis
Diabetes Care, 2003
Examining the metabolic and psychosocial impact of insulin pump therapy, this study concluded that insulin pumps improve glycemic control as compared with other therapies.
Copyright © 2003 American Diabetes Association
From Diabetes Care®, Vol. 26, 2003; 1079-1087
Reprinted with permission from The American Diabetes Association.
Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Regimens Using Insulin Lispro in Type 1 Diabetic Patients on Intensified Treatment
Diabetes Care, 2000
A randomized study compared the efficacy of two treatment regimes: continuous subcutaneous insulin infusion (insulin pump therapy) and multiple daily injections (MDI). Subjects using insulin pumps achieved much better glycemic control using less insulin than subjects using MDI.
Copyright © 2000 American Diabetes Association
From Diabetes Care®, Vol. 23, 2000; 1232-1235
Reprinted with permission from The American Diabetes Association.
Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes
Diabetes Care, 1996
This study compared the incidence of severe hypoglycemia in patients who switched to continuous subcutaneous insulin infusion (CSII) from multiple daily injections (MDI). It concluded that CSII therapy produced a “marked and sustained reduction” in hypoglycemia, due to the reproducible and flexible insulin delivery.
Copyright © 1996 American Diabetes Association
From Diabetes Care®, Vol. 19, 1996; 324-327
Reprinted with permission from The American Diabetes Association.
Free Demo Kit
Please note, you must have Adobe® Acrobat Reader® on your computer to view many of these articles. If you do not have this software, you can download a free copy.
Join Suite D
